Hikma has launched sodium acetate injection in 40 mEq per 20 mL vials in the United States. The product was approved with a Competitive Generic Therapy designation from the Food and Drug ...

Finding particulate matter in vials of Sodium Acetate Injection caused Chicago-area company Fresenius Kabi to recall seven lots of the sodium additive. Sodium Acetate Injection, USP, 400 mEq/100 mL (4 ...

MINNETONKA, Minn.--(BUSINESS WIRE)--Milla Pharmaceuticals Inc., an A.forall company, announced that its partner, Woodward Pharma Services LLC, has just commercialized its Supplemental Abbreviated New ...

Fresenius Kabi issued a voluntary recall of seven lots of sodium acetate intravenous fluid after testing found particulates of carbon and oxygen with traces of sodium, silicon, chromium, aluminum and ...

Through its U.S. subsidiary, Milla Pharmaceuticals Inc., A.forall announced the direct commercialization and launch of Sodium Acetate Injection 2mEq/mL in 20mL, 50mL, and 100mL vials. Sodium Acetate ...

MINNETONKA, Minn.--(BUSINESS WIRE)--Milla Pharmaceuticals, a subsidiary of the Alter Pharma Group, announced that it has received abbreviated new drug application (ANDA) approval from the U.S. Food ...

The Food and Drug Administration (FDA) announced that two injectable products by Fresenius Kabi USA have been discontinued. The decision was business-related and not due to safety or efficacy issues ...